APA (7th ed.) Citation

Tarantino, M. D., Kolodny, S., Zhang, J., Jamieson, B., & Vredenburg, M. (2023). Interim Analysis of Platelet Response in a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects after Switching from Eltrombopag (ELT) or Romiplostim (ROMI) to Avatrombopag (AVA). Blood, 142(Supplement 1), 2577. https://doi.org/10.1182/blood-2023-189908

Chicago Style (17th ed.) Citation

Tarantino, Michael D., Scott Kolodny, Jessica Zhang, Brian Jamieson, and Michael Vredenburg. "Interim Analysis of Platelet Response in a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects After Switching from Eltrombopag (ELT) or Romiplostim (ROMI) to Avatrombopag (AVA)." Blood 142, no. Supplement 1 (2023): 2577. https://doi.org/10.1182/blood-2023-189908.

MLA (9th ed.) Citation

Tarantino, Michael D., et al. "Interim Analysis of Platelet Response in a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects After Switching from Eltrombopag (ELT) or Romiplostim (ROMI) to Avatrombopag (AVA)." Blood, vol. 142, no. Supplement 1, 2023, p. 2577, https://doi.org/10.1182/blood-2023-189908.